Ronda Copher
About Ronda Copher
Ronda Copher is the Senior Director of Customer & Portfolio Value Generation and Hematology US HEOR at Bristol Myers Squibb, with extensive experience in Health Economics and Outcomes Research.
Current Position at Bristol Myers Squibb
Ronda Copher currently holds the position of Senior Director, Customer & Portfolio Value Generation at Bristol Myers Squibb. She has been with the company since January 2021. In this role, she is responsible for strategic initiatives focused on customer and portfolio value generation, ensuring comprehensive value propositions are developed for the company's hematology products.
Senior Director, Hematology US HEOR
Ronda Copher also serves as Senior Director, Hematology US HEOR at Bristol Myers Squibb. Her work in this position revolves around Health Economics and Outcomes Research (HEOR) for hematology products in the US market, contributing to the development and communication of product value propositions for market access.
Previous Experience at Celgene
Before joining Bristol Myers Squibb, Ronda Copher worked at Celgene as Senior Director, US HEOR, Hematology/Oncology. She was with the company from 2018 to 2019, based in Summit, New Jersey. In this role, she focused on evidence generation and value communication for hematology and oncology therapies.
Roles at Eisai US
Ronda Copher spent several years at Eisai US, holding multiple roles, including Director, Oncology Global Value & Access, and Director Oncology HEOR. She joined Eisai in 2011 and held various positions until 2018. Her work included developing global market access strategies and generating evidence for oncology products.
Educational Background
Ronda Copher pursued her higher education at the University of Minnesota-Twin Cities, where she achieved both a PhD and a Master of Arts in Sociology. She also holds a Bachelor of Arts in Sociology and Economics from Rutgers University - New Brunswick. Her extensive education has equipped her with a strong foundation in sociological research and economic analysis.